Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research

Grace C. Roberts, Carsten Zothner, Roland Remenyi, Andres Merits, Nicola J. Stonehouse, Mark Harris*

*Corresponding author for this work

Research output: Contribution to journalArticle

12 Citations (Scopus)
16 Downloads (Pure)


Chikungunya virus (CHIKV) is becoming an increasing global health issue which has spread across the globe and as far north as southern Europe. There is currently no vaccine or anti-viral treatment available. Although there has been a recent increase in CHIKV research, many of these in vitro studies have used a wide range of cell lines which are not physiologically relevant to CHIKV infection in vivo. In this study, we aimed to evaluate a panel of cell lines to identify a subset that would be both representative of the infectious cycle of CHIKV in vivo, and amenable to in vitro applications such as transfection, luciferase assays, immunofluorescence, western blotting and virus infection. Based on these parameters we selected four mammalian and two mosquito cell lines, and further characterised these as potential tools in CHIKV research.

Original languageEnglish
Article number14641
JournalScientific Reports
Issue number1
Publication statusPublished - 01 Dec 2017

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research'. Together they form a unique fingerprint.

  • Cite this